In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood

Anti-cancer Drugs
H J G D van den BongardJan H M Schellens

Abstract

E7070 is a novel sulfonamide anticancer agent that arrests the G(1)/S phase of the cell cycle. Preclinical and phase I studies have demonstrated non-linear pharmacokinetics (PK) of the drug. A population PK analysis revealed that the human plasma concentration-time data were best described by a three-compartment model with non-linear distribution. We have studied the in vitro interaction of 14C-radiolabeled E7070 with red blood cells (RBC) and its binding to plasma proteins in the concentration range where non-linearity in disposition was observed in humans to get more insight into the behavior of the drug. After the addition of E7070 to whole blood at 37 degrees C, the drug is taken up or binds to RBC in a concentration-dependent manner. The addition of sodium azide, however, did not result in a decrease of drug uptake by RBC, indicating passive diffusion processes. A non-linear increase in drug uptake was observed at incubation concentrations above 4 microg/ml E7070 in whole blood. This non-linearity was confirmed by lower partition coefficients between RBC and plasma at higher incubation concentrations (from 2.37 at 4 microg/ml to 0.31 at 200 microg/ml). The plasma protein binding of E7070 was high (98-99%) and linear in the...Continue Reading

References

Jan 1, 1976·Annual Review of Pharmacology and Toxicology·T H Maren
Jun 1, 1991·Clinical Pharmacokinetics·T M Ludden
Jan 1, 1984·Annals of the New York Academy of Sciences·J T Edsall
Dec 6, 1996·Science·C J Sherr
Oct 3, 1999·Journal of Medicinal Chemistry·T OwaK Kitoh
Mar 11, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A S Lundberg, R A Weinberg
Nov 18, 2000·British Journal of Pharmacology·S Trapp, F M Ashcroft
Apr 20, 2001·Bioorganic & Medicinal Chemistry·Claudiu T SupuranA Scozzafava
Oct 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y OzawaK Yoshimatsu
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ch Van KesterenEarly Clinical Studies Group of the European Organization for Research and Treatment of Cancer
Oct 24, 2002·Anti-cancer Drugs·H J G Desirée van sen BongardJos H Beijnen

Citations

Aug 28, 2014·Computational and Mathematical Methods in Medicine·Liu Hongjiu, Hu Yanrong
Oct 20, 2005·Cancer Science·Yasuhide YamadaTomohide Tamura
Jul 24, 2004·Critical Reviews in Clinical Laboratory Sciences·H DumezErnst A de Bruijn
Sep 2, 2006·Journal of Pharmacokinetics and Pharmacodynamics·Anthe S ZandvlietAlwin D R Huitema
Mar 28, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anthe S ZandvlietAlwin D R Huitema
Dec 5, 2020·Future Medicinal Chemistry·Ranjeet P DashNuggehally R Srinivas

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.

Related Papers

Antimicrobial Agents and Chemotherapy
G L Jungbluth, W J Jusko
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ch Van KesterenEarly Clinical Studies Group of the European Organization for Research and Treatment of Cancer
© 2021 Meta ULC. All rights reserved